SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193805-18-000748
Filing Date
2018-05-23
Accepted
2018-05-23 12:02:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 e618029_sc13da-at.htm SC 13D/A 27171
2 e618029_ex-k.htm EX-99.K 12719
3 e618029_ex-l.htm EX-99.L 91507
  Complete submission text file 0001193805-18-000748.txt   132757
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Subject) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87471 | Film No.: 18854561
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address
Payne Joseph E (Filed by) CIK: 0001727315 (see all company filings)

Type: SC 13D/A